Utility of antimüllerian hormone level obtained for infertility assessment for alerting to ovarian tumor.
BACKGROUND
Antimüllerian hormone is a marker of ovarian reserve and is now routinely measured in women seeking infertility treatment.


METHODS
A 42-year-old woman, gravida 1, abortus 1, presented with secondary infertility. Obtained originally for assessment of ovarian reserve, an antimüllerian hormone of more than 160 ng/mL raised suspicion for a granulosa cell tumor. A laparoscopic right salpingo-oophorectomy, pelvic washings, dilation and curettage, and peritoneal and omental biopsies were performed. A well-differentiated granulosa cell tumor confined to the right ovary was consistent with stage 1A disease.


CONCLUSIONS
As the use of antimüllerian hormone becomes more common for ovarian reserve testing, providers need to maintain an awareness for neoplastic disease with abnormal values.
Department of Gynecology and Obstetrics, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Bryan J
BJ
Hill
Travis J
TJ
Morrell
Mallory M
MM
Zhang
John M
JM
Norian
D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006106:Granulosa Cell Tumor / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D006801:Humans; D007247:Infertility, Female / Q000097:blood; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D010052:Ovariectomy; D058994:Salpingectomy
D014408:Biomarkers, Tumor; D054304:Anti-Mullerian Hormone